Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies

Ageing Research Reviews

Volumn 12, Issue 2, 2013, Pages 708-718

  Schöttker, Ben ^a   Ball, Dorothee ^a   Gellert, Carolin ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cohort Studies; Elderly; Meta analysis; Mortality; Review; Systematic; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

BIBLIOGRAPHIC DATABASE; COHORT ANALYSIS; EMBASE; GERIATRIC PATIENT; HUMAN; ISI WEB OF KNOWLEDGE; MEDLINE; MORTALITY; PROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL;

ADULT; AGED; COHORT STUDIES; DIETARY SUPPLEMENTS; HUMANS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84878536138     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2012.02.004     Document Type: Review

References (102)

1. Adami P.E., Negro A., Lala N., Martelletti P. The role of physical activity in the prevention and treatment of chronic diseases. Clin. Ter. 2010, 161:537-541.
2. Adorini L., Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 2008, 4:404-412.
3. Anderson J.L., May H.T., Horne B.D., Bair T.L., Hall N.L., Carlquist J.F., Lappe D.L., Muhlestein J.B. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 2010, 106:963-968.
4. Autier P., Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 2007, 167:1730-1737.
5. Bates, C.J., Hamer, M., and Mishra, G.D., 2011. A study of relationships between bone-related vitamins and minerals, related risk markers, and subsequent mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over. Osteoporos. Int.,. doi:10.1007/s00198-011-1543-z.
6. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005, 293:2257-2264.
7. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 2006, 84:18-28.
8. Bjelakovic G., Gluud L.L., Nikolova D., Whitfield K., Wetterslev J., Simonetti R.G., Bjelakovic M., Gluud C. Vitamin D supplementation for prevention of mortality in adults. Cochrane. Database Syst. Rev. 2011, CD007470.
9. Blunt J.W., DeLuca H.F., Schnoes H.K. 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry 1968, 7:3317-3322.
10. Bolland M.J., Bacon C.J., Horne A.M., Mason B.H., Ames R.W., Wang T.K., Grey A.B., Gamble G.D., Reid I.R. Vitamin D insufficiency and health outcomes over 5 y in older women. Am. J. Clin. Nutr. 2010, 91:82-89.
11. Bolland M.J., Grey A., Gamble G.D., Reid I.R. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am. J. Clin. Nutr. 2011, 94:1144-1149.
12. Brewer L.C., Michos E.D., Reis J.P. Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr. Drug Targets 2011, 12:54-60.
13. Brown A.J., Dusso A., Slatopolsky E. Vitamin D. Am. J. Physiol. 1999, 277:F157-F175.
14. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., Garland C.F., Giovannucci E. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006, 134:1129-1140.
15. Cawthon P.M., Parimi N., Barrett-Connor E., Laughlin G.A., Ensrud K.E., Hoffman A.R., Shikany J.M., Cauley J.A., Lane N.E., Bauer D.C., Orwoll E.S., Cummings S.R. Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J. Clin. Endocrinol. Metab. 2010, 95:4625-4634.
16. Chen S., Glenn D.J., Ni W., Grigsby C.L., Olsen K., Nishimoto M., Law C.S., Gardner D.G. Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension 2008, 52:1106-1112.
17. Chiu K.C., Chu A., Go V.L., Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 2004, 79:820-825.
18. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Food Nutrition Board, Institute of Medicine Dietary Reference Intakes for Calcium and Vitamin D 2011, National Academies Press, 500 Fifth Street, N.W., Lockbox 285, Washington DC, USA. R. Catharine, C.L. Taylor, A.L. Yaktine, H.B. Del Valle (Eds.).
19. Deeb K.K., Trump D.L., Johnson C.S. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer 2007, 7:684-700.
20. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
21. Di R.M., Malaguarnera M., Nicoletti F., Malaguarnera L. Vitamin D3: a helpful immuno-modulator. Immunology 2011, 134:123-139.
22. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
23. Elamin M.B., Abu Elnour N.O., Elamin K.B., Fatourechi M.M., Alkatib A.A., Almandoz J.P., Liu H., Lane M.A., Mullan R.J., Hazem A., Erwin P.J., Hensrud D.D., Murad M.H., Montori V.M. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2011, 96:1931-1942.
24. Fitzpatrick L.A., Bilezikian J.P., Silverberg S.J. Parathyroid hormone and the cardiovascular system. Curr. Osteoporos. Rep. 2008, 6:77-83.
25. Forman J.P., Williams J.S., Fisher N.D. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010, 55:1283-1288.
26. Fraser D.R., Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature 1970, 228:764-766.
27. Gandini S., Boniol M., Haukka J., Byrnes G., Cox B., Sneyd M.J., Mullie P., Autier P. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int. J. Cancer 2011, 128:1414-1424.
28. Garland C.F., French C.B., Baggerly L.L., Heaney R.P. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res. 2011, 31:607-611.
29. Garland C.F., Gorham E.D., Mohr S.B., Garland F.C. Vitamin D for cancer prevention: global perspective. Ann. Epidemiol. 2009, 19:468-483.
30. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2009, 169:384-390.
31. Grandi N.C., Breitling L.P., Brenner H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev. Med. 2010, 51:228-233.
32. Grant W.B. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: an examination using Hill's criteria for causality. Dermatoendocrinol 2009, 1:17-24.
33. Grant W.B. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur. J. Clin. Nutr. 2011, 65:1016-1026.
34. Grant W.B. Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol 2011, 3:199-204.
35. Grant W.B., Juzeniene A., Moan J.E. Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries. Scand. J. Public Health 2011, 39:70-78.
36. Greenland S., Longnecker M.P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am. J. Epidemiol. 1992, 135:1301-1309.
37. Hagenau T., Vest R., Gissel T.N., Poulsen C.S., Erlandsen M., Mosekilde L., Vestergaard P. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos. Int. 2009, 20:133-140.
38. Hagstrom E., Hellman P., Larsson T.E., Ingelsson E., Berglund L., Sundstrom J., Melhus H., Held C., Lind L., Michaelsson K., Arnlov J. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009, 119:2765-2771.
39. Hansson G.K., Libby P., Schonbeck U., Yan Z.Q. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res. 2002, 91:281-291.
40. Hathcock J.N., Shao A., Vieth R., Heaney R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007, 85:6-18.
41. Heaney R.P., Recker R.R., Grote J., Horst R.L., Armas L.A. Vitamin D(3) is more potent than vitamin D(2) in humans. J. Clin. Endocrinol. Metab. 2011, 96:E447-E452.
42. Holick M.F. Evolution and function of vitamin D. Recent Results Cancer Res. 2003, 164(3-28):3-28.
43. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
44. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96:1911-1930.
45. Hutchinson M.S., Grimnes G., Joakimsen R.M., Figenschau Y., Jorde R. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study. Eur. J. Endocrinol. 2010, 162:935-942.
46. Jia X., Aucott L.S., McNeill G. Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br. J. Nutr. 2007, 98:593-599.
47. Jorde R., Sneve M., Hutchinson M., Emaus N., Figenschau Y., Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am. J. Epidemiol. 2010, 171:903-908.
48. Kennel K.A., Drake M.T., Hurley D.L. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin. Proc. 2010, 85:752-757.
49. Kestenbaum B., Katz R., de Boer I., Hoofnagle A., Sarnak M.J., Shlipak M.G., Jenny N.S., Siscovick D.S. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J. Am. Coll. Cardiol. 2011, 58:1433-1441.
50. Kilkkinen A., Knekt P., Aro A., Rissanen H., Marniemi J., Heliovaara M., Impivaara O., Reunanen A. Vitamin D status and the risk of cardiovascular disease death. Am. J. Epidemiol. 2009, 170:1032-1039.
51. Knekt P., Laaksonen M., Mattila C., Harkanen T., Marniemi J., Heliovaara M., Rissanen H., Montonen J., Reunanen A. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008, 19:666-671.
52. Krishnan A.V., Trump D.L., Johnson C.S., Feldman D. The role of vitamin D in cancer prevention and treatment. Endocrinol. Metab. Clin. North Am. 2010, 39:401-418.
53. Kuroda T., Shiraki M., Tanaka S., Ohta H. Contributions of 25-hydroxyvitamin D. Bone 2009, 44:168-172.
54. Lamprecht S.A., Lipkin M. Chemoprevention of colon cancer by calcium vitamin D and folate: molecular mechanisms. Nat. Rev. Cancer 2003, 3:601-614.
55. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 2007, 85:1586-1591.
56. Li Y.C., Qiao G., Uskokovic M., Xiang W., Zheng W., Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J. Steroid Biochem. Mol. Biol. 2004, 89-90:387-392.
57. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 2001, 22:477-501.
58. Macdonald H.M., Mavroeidi A., Fraser W.D., Darling A.L., Black A.J., Aucott L., O'Neill F., Hart K., Berry J.L., Lanham-New S.A., Reid D.M. Sunlight and dietary contributions to the seasonal vitamin D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern?. Osteoporos. Int. 2011, 22:2461-2472.
59. Makariou S., Liberopoulos E.N., Elisaf M., Challa A. Novel roles of vitamin D in disease: what is new in 2011?. Eur. J. Intern. Med. 2011, 22:355-362.
60. Melamed M.L., Michos E.D., Post W., Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 2008, 168:1629-1637.
61. Michaelsson K., Baron J.A., Snellman G., Gedeborg R., Byberg L., Sundstrom J., Berglund L., Arnlov J., Hellman P., Blomhoff R., Wolk A., Garmo H., Holmberg L., Melhus H. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am. J. Clin. Nutr. 2010, 92:841-848.
62. Mithal A., Wahl D.A., Bonjour J.P., Burckhardt P., Dawson-Hughes B., Eisman J.A., El-Hajj F.G., Josse R.G., Lips P., Morales-Torres J. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos. Int. 2009, 20:1807-1820.
63. Mitri J., Muraru M.D., Pittas A.G. Vitamin D and type 2 diabetes: a systematic review. Eur. J. Clin. Nutr. 2011, 65:1005-1015.
64. Mosekilde L. Vitamin D and the elderly. Clin. Endocrinol. (Oxf). 2005, 62:265-281.
65. Murad M.H., Elamin K.B., Abu Elnour N.O., Elamin M.B., Alkatib A.A., Fatourechi M.M., Almandoz J.P., Mullan R.J., Lane M.A., Liu H., Erwin P.J., Hensrud D.D., Montori V.M. The effect of vitamin D on falls: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2011, 96:2997-3006.
66. O'Donnell S., Cranney A., Horsley T., Weiler H.A., Atkinson S.A., Hanley D.A., Ooi D.S., Ward L., Barrowman N., Fang M., Sampson M., Tsertsvadze A., Yazdi F. Efficacy of food fortification on serum 25-hydroxyvitamin D concentrations: systematic review. Am. J. Clin. Nutr. 2008, 88:1528-1534.
67. Parker J., Hashmi O., Dutton D., Mavrodaris A., Stranges S., Kandala N.B., Clarke A., Franco O.H. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010, 65:225-236.
68. Pilz S., Tomaschitz A., Obermayer-Pietsch B., Dobnig H., Pieber T.R. Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res. 2009, 29:3699-3704.
69. Pilz S., Tomaschitz A., Ritz E., Pieber T.R. Vitamin D status and arterial hypertension: a systematic review. Nat. Rev. Cardiol. 2009, 6:621-630.
70. Pilz S., Dobnig H., Nijpels G., Heine R.J., Stehouwer C.D., Snijder M.B., Van Dam R.M., Dekker J.M. Vitamin D and mortality in older men and women. Clin. Endocrinol. (Oxf) 2009, 71:666-672.
71. Pilz S., Iodice S., Zittermann A., Grant W.B., Gandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am. J. Kidney Dis. 2011, 58:374-382.
72. Pilz S., Tomaschitz A., Friedl C., Amrein K., Drechsler C., Ritz E., Boehm B.O., Grammer T.B., Marz W. Vitamin D status and mortality in chronic kidney disease. Nephrol. Dial. Transplant. 2011, 26:3603-3609.
73. Pilz, S., Tomaschitz, A., Marz, W., Drechsler, C., Ritz, E., Zittermann, A., Cavalier, E., Pieber, T.R., Lappe, J.M., Grant, W.B., Holick, M.F., Dekker, J.M., 2011. Vitamin D, cardiovascular disease and mortality. Clin. Endocrinol. (Oxf). doi:10.1111/j.%201365-2265.2011.04147.x.
74. Pittas A.G., Chung M., Trikalinos T., Mitri J., Brendel M., Patel K., Lichtenstein A.H., Lau J., Balk E.M. Systematic review: vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 2010, 152:307-314.
75. Pittas A.G., Lau J., Hu F.B., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2007, 92:2017-2029.
76. Reichrath J., Nurnberg B. Cutaneous vitamin D synthesis versus skin cancer development: The Janus faces of solar UV-radiation. Dermatoendocrinol 2009, 1:253-261.
77. Rothstein H.R., Sutton A.J., Borenstein M. Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments 2005, Wiley, Chichester, England.
78. Saggese G., Federico G., Balestri M., Toniolo A. Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J. Endocrinol. Invest. 1989, 12:329-335.
79. Saleh F.N., Schirmer H., Sundsfjord J., Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur. Heart J. 2003, 24:2054-2060.
80. Sambrook P.N., Chen J.S., March L.M., Cameron I.D., Cumming R.G., Lord S.R., Schwarz J., Seibel M.J. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J. Clin. Endocrinol. Metab. 2004, 89:5477-5481.
81. Scragg R., Camargo C.A. Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 2008, 168:577-586.
82. Semba R.D., Houston D.K., Bandinelli S., Sun K., Cherubini A., Cappola A.R., Guralnik J.M., Ferrucci L. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur. J. Clin. Nutr. 2010, 64:203-209.
83. Semba R.D., Houston D.K., Ferrucci L., Cappola A.R., Sun K., Guralnik J.M., Fried L.P. Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women. Nutr. Res. 2009, 29:525-530.
84. Slomski A. IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. JAMA 2011, 305(453-454):456.
85. Snijder M.B., Lips P., Seidell J.C., Visser M., Deeg D.J., Dekker J.M., Van Dam R.M. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J. Intern. Med. 2007, 261:558-565.
86. Sokol S.I., Tsang P., Aggarwal V., Melamed M.L., Srinivas V.S. Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol. Rev. 2011, 19:192-201.
87. Souberbielle J.C., Body J.J., Lappe J.M., Plebani M., Shoenfeld Y., Wang T.J., Bischoff-Ferrari H.A., Cavalier E., Ebeling P.R., Fardellone P., Gandini S., Gruson D., Guerin A.P., Heickendorff L., Hollis B.W., Ish-Shalom S., Jean G., von L.P., Largura A., Olsson T., Pierrot-Deseilligny C., Pilz S., Tincani A., Valcour A., Zittermann A. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun. Rev. 2010, 9:709-715.
88. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., Moher D., Becker B.J., Sipe T.A., Thacker S.B. Meta-analysis of observational studies in epidemiology: a proposal for reporting, Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
89. Szulc P., Claustrat B., Delmas P.D. Serum concentrations of 17beta-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men - the MINOS study. Clin. Endocrinol. (Oxf) 2009, 71:594-602.
90. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326:469.
91. Veldman C.M., Cantorna M.T., DeLuca H.F. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch. Biochem. Biophys. 2000, 374:334-338.
92. Virtanen J.K., Nurmi T., Voutilainen S., Mursu J., Tuomainen T.P. Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur. J. Nutr. 2011, 50:305-312.
93. Visser M., Deeg D.J., Puts M.T., Seidell J.C., Lips P. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am. J. Clin. Nutr. 2006, 84:616-622.
94. Wactawski-Wende J., Kotchen J.M., Anderson G.L., Assaf A.R., Brunner R.L., O'Sullivan M.J., Margolis K.L., Ockene J.K., Phillips L., Pottern L., Prentice R.L., Robbins J., Rohan T.E., Sarto G.E., Sharma S., Stefanick M.L., Van H.L., Wallace R.B., Whitlock E., Bassford T., Beresford S.A., Black H.R., Bonds D.E., Brzyski R.G., Caan B., Chlebowski R.T., Cochrane B., Garland C., Gass M., Hays J., Heiss G., Hendrix S.L., Howard B.V., Hsia J., Hubbell F.A., Jackson R.D., Johnson K.C., Judd H., Kooperberg C.L., Kuller L.H., LaCroix A.Z., Lane D.S., Langer R.D., Lasser N.L., Lewis C.E., Limacher M.C., Manson J.E. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 2006, 354:684-696.
95. Wang L., Manson J.E., Song Y., Sesso H.D. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 2010, 152:315-323.
96. Welsh, J., 2011. Cellular and molecular effects of vitamin D on carcinogenesis. Arch. Biochem. Biophys. doi:10.1016/j.abb.2011.10.019.
97. Witham M.D., Nadir M.A., Struthers A.D. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J. Hypertens. 2009, 27:1948-1954.
98. Wolden-Kirk H., Overbergh L., Christesen H.T., Brusgaard K., Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol. Cell. Endocrinol. 2011, 347:106-120.
99. Yin L., Grandi N., Raum E., Haug U., Arndt V., Brenner H. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment. Pharmacol. Ther. 2009, 30:113-125.
100. Yin L., Raum E., Haug U., Arndt V., Brenner H. Meta-analysis of longitudinal studies: serum vitamin D and prostate cancer risk. Cancer Epidemiol. 2009, 33:435-445.
101. Zittermann A., Iodice S., Pilz S., Grant W.B., Bagnardi V., Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 2012, 95:91-100.
102. Zittermann A., Schleithoff S.S., Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 2005, 94:483-492.